Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Disease models from pluripotent stem cells.

Lengerke C, Daley GQ.

Ann N Y Acad Sci. 2009 Sep;1176:191-6. doi: 10.1111/j.1749-6632.2009.04962.x.

PMID:
19796247
2.

Determinants of pluripotency: from avian, rodents, to primates.

Martins-Taylor K, Xu RH.

J Cell Biochem. 2010 Jan 1;109(1):16-25. doi: 10.1002/jcb.22402. Review.

PMID:
19937733
3.

The potential of embryonic stem cells combined with -omics technologies as model systems for toxicology.

Winkler J, Sotiriadou I, Chen S, Hescheler J, Sachinidis A.

Curr Med Chem. 2009;16(36):4814-27. Review.

PMID:
19929785
4.
5.

Stem cells and nuclear reprogramming.

Saric T, Hescheler J.

Minim Invasive Ther Allied Technol. 2008;17(2):64-78. doi: 10.1080/13645700801969303. Review.

PMID:
18465442
6.

Understanding pluripotency--how embryonic stem cells keep their options open.

Johnson BV, Shindo N, Rathjen PD, Rathjen J, Keough RA.

Mol Hum Reprod. 2008 Sep;14(9):513-20. doi: 10.1093/molehr/gan048. Epub 2008 Aug 20. Review.

PMID:
18716052
7.

Human stem cells as a model for cardiac differentiation and disease.

Beqqali A, van Eldik W, Mummery C, Passier R.

Cell Mol Life Sci. 2009 Mar;66(5):800-13. doi: 10.1007/s00018-009-8476-0. Review.

PMID:
19151924
8.

[Induced pluripotent stem cells (iPS cells)].

Germain D.

Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):555-9. doi: 10.1016/j.patbio.2009.09.017. Epub 2009 Oct 31. Review. French.

PMID:
19880264
9.

Pluripotent stem cells.

Verfaillie C.

Transfus Clin Biol. 2009 May;16(2):65-9. doi: 10.1016/j.tracli.2009.04.006. Epub 2009 May 12. Review.

PMID:
19442552
10.

Pluripotency: toward a gold standard for human ES and iPS cells.

Smith KP, Luong MX, Stein GS.

J Cell Physiol. 2009 Jul;220(1):21-9. doi: 10.1002/jcp.21681. Review.

PMID:
19326392
11.

Induced pluripotent stem cells and promises of neuroregenerative medicine.

Verma A, Verma N.

Neurol India. 2011 Jul-Aug;59(4):555-7. doi: 10.4103/0028-3886.84337. Review.

12.

Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.

Freund C, Mummery CL.

J Cell Biochem. 2009 Jul 1;107(4):592-9. doi: 10.1002/jcb.22164. Review.

PMID:
19449339
13.

Modeling epilepsy with pluripotent human cells.

Muotri AR.

Epilepsy Behav. 2009 Jan;14 Suppl 1:81-5. doi: 10.1016/j.yebeh.2008.09.021. Epub 2008 Oct 19. Review.

PMID:
18845273
14.

Human embryonic stem cells: challenges and opportunities.

Stice SL, Boyd NL, Dhara SK, Gerwe BA, Machacek DW, Shin S.

Reprod Fertil Dev. 2006;18(8):839-46. Review.

PMID:
17147932
15.

Induced pluripotency of mouse and human somatic cells.

Maherali N, Hochedlinger K.

Cold Spring Harb Symp Quant Biol. 2008;73:157-62. doi: 10.1101/sqb.2008.73.017. Epub 2008 Nov 6. Review.

PMID:
19022751
16.

Transplantation tolerance in an age of induced pluripotency.

Fairchild PJ.

Curr Opin Organ Transplant. 2009 Aug;14(4):321-5. doi: 10.1097/MOT.0b013e32832e9424. Review.

PMID:
19542888
17.

Roles of TGF-beta family signaling in stem cell renewal and differentiation.

Watabe T, Miyazono K.

Cell Res. 2009 Jan;19(1):103-15. doi: 10.1038/cr.2008.323. Review.

PMID:
19114993
18.

[Advance in study of induced pluripotent stem cells (iPS cells)].

Aoi T.

Nihon Rinsho. 2008 May;66(5):850-6. Review. Japanese.

PMID:
18464501
19.

Genome modification in human embryonic stem cells.

Tenzen T, Zembowicz F, Cowan CA.

J Cell Physiol. 2010 Feb;222(2):278-81. doi: 10.1002/jcp.21948. Review.

PMID:
19877154
20.

The tumorigenicity of human embryonic stem cells.

Blum B, Benvenisty N.

Adv Cancer Res. 2008;100:133-58. doi: 10.1016/S0065-230X(08)00005-5. Review.

PMID:
18620095

Supplemental Content

Support Center